An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
Ted Rogers Chair in Heart Function Outcomes Dr. Douglas Lee leads new Heart-Brain Connection $3 million IMPACT Award project
Four unique educational events in October and December
Via unique research grants, the Ted Rogers Centre funds impactful projects that show the most promise in transforming how we diagnose, treat and prevent heart failure.
Our Innovation Fund is open to bench research, proof-of-concept development and the clinical assessment of new innovations – meaning it can play a key role in propelling great ideas forward. Whereas major government grant competitions tend to be more risk averse, we encourage lofty but achievable targets that demonstrate scientific merit.
Note: While projects must involve at least 2 of the Centre’s 3 partners – SickKids, University Health Network, University of Toronto – any collaborators worldwide may be co-applicants.
Renewable grants up to $100,000 for innovative projects that transform our understanding or approach to heart failure.
This year, we have partnered with the Mitochondrial Innovation Initiative (MITO2i) to host a second seed grant of $100,000/year (renewable) for projects that target mitochondrial disease, heart failure, and associated conditions.
Notes: Each application is linked to one account. We recommend electing a representative/primary applicant to create an account that can be shared across co-applicants. If you have any questions about the competition, email Purva Mehta (Coordinator, Planning and Operations) at purva.mehta@uhn.research.ca.
Innovate
Collaborate
Build Knowledge
Transform Care
Change Lives
Up to $500,000 for projects that target the cardiovascular complications of COVID-19.
Renewable grants up to $100,000 for innovative projects that transform our understanding or approach to heart failure.
Up to $1 million over 3 years for transformative research projects seeking to discover, develop and implement new innovations and therapies. Commercialization potential is a key factor.
Up to $100,000 grants that were awarded in partnership with Medicine by Design.